Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:2416-2422
Published online before print May 6, 2002, doi: 10.1161/01.CIR.0000016065.90068.96
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/20/2416    most recent
01.CIR.0000016065.90068.96v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by George, J.
Right arrow Articles by Keren, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by George, J.
Right arrow Articles by Keren, G.
Related Collections
Right arrow Pathophysiology
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2002;105:2416.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Functional Inhibition of Ras by S-trans,trans-Farnesyl Thiosalicylic Acid Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice

Jacob George, MD*; Arnon Afek, MD*; Pnina Keren, PhD; Itzhak Herz, MD; Iris Goldberg, PhD; Roni Haklai, PhD; Yoel Kloog, PhD; Gad Keren, MD

From the Department of Cardiology and the Cardiovascular Research Laboratory, Tel Aviv Sourasky Medical Center (J.G., P.K., I.H., G.K.), Tel Aviv, Israel; the Institute of Pathology, Sheba Medical Center (A.A., I.G.), Tel-Hashomer, Israel; and the Department of Neurobiochemistry, Tel Aviv University (R.H., Y.K.), Tel Aviv, Israel.

Correspondence to Gad Keren, MD, Department of Cardiology, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv 64239, Israel. E-mail kereng{at}tasmc.health.gov.il

Background Atherosclerosis is a multifactorial disorder involving inflammatory processes. These responses are associated with robust activation of signaling cascades by diverse cell surface receptors in a variety of cell types. The processes that are involved in atherosclerosis would likely require intact Ras pathways, which play a key role in the control of cell growth, differentiation, and apoptosis.

Methods and Results We examined whether the Ras inhibitor farnesyl thiosalicylic acid (FTS) can suppress atherogenesis in the apolipoprotein E–deficient mouse model. Mice were treated with FTS or a control regimen 3 times weekly for 6 weeks and fed a normal chow diet. Two additional groups included FTS-treated and control-treated mice that were fed a high-fat diet for 10 weeks. FTS reduced both fatty streaks and advanced lesions compared with the control treatment. Ras inhibition in vivo was evidenced by the reduced content of the active form of Ras (Ras-GTP) in aortas of FTS-treated mice. Splenocytes from the FTS-treated versus control mice exhibited reduced proliferation to oxidized LDL (OxLDL) but not to concanavalin A. IgG anti-OxLDL antibody levels were reduced in FTS-treated mice compared with controls. Whereas no effect of FTS was evident on plaque T lymphocyte and macrophage content, lesional vascular cell adhesion molecule-1 and nuclear factor-{kappa}B expression were considerably reduced compared with controls.

Conclusions FTS suppressed atherosclerotic plaques in apolipoprotein E–deficient mice, providing a useful tool for research in atherosclerosis.


Key Words: atherosclerosis • Ras • immune system • apolipoproteins




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sugita, H. Sugita, and M. Kaneki
Farnesyltransferase Inhibitor, Manumycin A, Prevents Atherosclerosis Development and Reduces Oxidative Stress in Apolipoprotein E-Deficient Mice
Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1390 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Minamino and I. Komuro
Vascular Cell Senescence: Contribution to Atherosclerosis
Circ. Res., January 5, 2007; 100(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. George, A. Afek, A. Abashidze, H. Shmilovich, V. Deutsch, J. Kopolovich, H. Miller, and G. Keren
Transfer of Endothelial Progenitor and Bone Marrow Cells Influences Atherosclerotic Plaque Size and Composition in Apolipoprotein E Knockout Mice
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2636 - 2641.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. S. Rosenson-Schloss, E. Chnari, T. A. Brieva, A. Dang, and P. V. Moghe
Glutathione Preconditioning Attenuates Ac-LDL-Induced Macrophage Apoptosis via Protein Kinase C-Dependent Ac-LDL Trafficking
Experimental Biology and Medicine, January 1, 2005; 230(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Minamino, T. Yoshida, K. Tateno, H. Miyauchi, Y. Zou, H. Toko, and I. Komuro
Ras Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis
Circulation, November 4, 2003; 108(18): 2264 - 2269.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
C. Barandier, X.-F. Ming, and Z. Yang
Small G Proteins as Novel Therapeutic Targets in Cardiovascular Medicine
Physiology, February 1, 2003; 18(1): 18 - 22.
[Abstract] [Full Text] [PDF]